(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate

(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate Suppliers list
Company Name: Nanjing Vcare PharmaTech Co., Ltd  
Tel: 025-58741518 13327700685
Email: sales@vcarepharmatech.com
Products Intro: Product Name:Benzeneacetic acid, 2-[[6-[2-(aminocarbonyl)phenoxy]-4-pyrimidinyl]oxy]-α-(methoxymethylene)-, methyl ester, (E)- (9CI)
CAS:131860-82-7
Purity:98% Package:1g;10g;100g;10kg;100kg Remarks:82-5
(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate Basic information
Product Name:(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate
Synonyms:(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate;Benzeneacetic acid, 2-[[6-[2-(aminocarbonyl)phenoxy]-4-pyrimidinyl]oxy]-α-(methoxymethylene)-, methyl ester, (E)- (9CI)
CAS:131860-82-7
MF:C22H19N3O6
MW:421.40276
EINECS:
Product Categories:
Mol File:131860-82-7.mol
(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate Structure
(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate Chemical Properties
Safety Information
MSDS Information
(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate Usage And Synthesis
(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate Preparation Products And Raw materials
Tag:(E)-Methyl 2-(2-((6-(2-carbaMoylphenoxy)pyriMidin-4-yl)oxy)phenyl)-3-Methoxyacrylate(131860-82-7) Related Product Information

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept